shortagewatch

Home / Companies / Dr. Reddy's

Company family · HQ IN

Dr. Reddy's: medicine shortages

RDY · NYSE / NSE

As of 2 Nov 2026, 40 Dr. Reddy's products have a reported shortage across 5 countries, covering 24 medicines.

Products short40rank #48 of 464
Medicines24active ingredients
Countries5/16
New in 90 days14-1 vs market pace
Typical duration4 monthsmedian so far
Manufacturing38%demand-driven 50%

Where

United States1Canada4Italy19Spain15Austria1

Which therapeutic classes

Cancer and immune system25Anti-infectives5Blood5Digestive tract and metabolism2Various2Cardiovascular system1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Dr. Reddy'sDr. Reddy's: Manufacturing problem 9 (22%)22%Dr. Reddy's: Increased demand 12 (30%)30%Dr. Reddy's: Distribution or logistics 1 (2%)Dr. Reddy's: Commercial decision or withdrawal 1 (2%)Dr. Reddy's: Other 1 (2%)Dr. Reddy's: Not stated 16 (40%)40%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

Open shortages over time

3435353631 Oct2026-10-31: 351 Nov2026-11-01: 352 Nov2026-11-02: 35

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

025710Dec: 0Jan ’25: 0Feb: 1FebMar: 0Apr: 0May: 1MayJun: 2Jul: 2Aug: 1AugSep: 0Oct: 2Nov: 0NovDec: 0Jan ’26: 2Feb: 1FebMar: 0Apr: 1May: 2MayJun: 0Jul: 6Aug: 4AugSep: 4Oct: 6Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0257102018: 1120182020: 2220202021: 6620212022: 101020222023: 4420232026: 442026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Dr. Reddy's40

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Dr. Reddy's: 40 / 24Dr. Reddy's

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Nintedanib49 Sep 2026Increased demand4/16
Pirfenidone46 Jul 2025Manufacturing problem6/16
Eltrombopag31 Jul 2026Manufacturing problem4/16
Bendamustine211 May 2025Not stated7/16
Daptomycin231 May 2026Increased demand5/16
Entecavir23 Aug 2025Not stated8/16
Rituximab22 Oct 2025Not stated2/16
Rivaroxaban215 Jul 2026Increased demand13/16
Semaglutide220 Jul 2026Manufacturing problem3/16
Sugammadex21 Jan 2024Increased demand6/16
Sunitinib228 Feb 2025Increased demand5/16
Azacitidine118 Dec 2020Not stated6/16
Bortezomib131 May 2026Increased demand5/16
Bosentan114 Sep 2026Distribution or logistics7/16
Bosutinib118 Jul 2025Increased demand2/16
Cyclophosphamide19 Feb 2026Not stated12/16
Dasatinib16 Jan 2022Manufacturing problem6/16
Dimethyl Fumarate116 Jul 2026Manufacturing problem5/16
Everolimus113 Oct 2026Not stated3/16
Fulvestrant12 Oct 2026Increased demand5/16
Imatinib116 Nov 2026Manufacturing problem6/16
Oxaliplatin122 Apr 2026Other10/16
Raltegravir115 Oct 2026Not stated1/16
Teriflunomide116 Jun 2025Increased demand4/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.